drugset / Trial / NCT02957396
Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects
RandomizedCrossoverOpen-labelOther
Summary
Finerenone is developed for the treatment of diabetic kidney disease (adults) and chronic kidney disease (children). The purpose of the proposed trial is to test the pharmacokinetics of a novel liquid formulation for the treatment of children in comparison to the adult tablet formulation.
Timeline
- Start
- 2016-11-17
- Primary completion
- 2017-01-13
- Completion
- 2017-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Finerenone | Small molecule | 20 mg | Oral |
Indications
No indication recorded.